Factive (Gemifloxacin Mesylate) Drug Information: Uses, Side ...
Learn about the prescription medication Factive (Gemifloxacin Mesylate), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
DailyMed: About DailyMed
Each white to off-white, oval, film-coated FACTIVE tablet has breaklines and GE 320 debossed on both faces and contains gemifloxacin mesylate equivalent to 320 mg gemifloxacin. The inactive ingredients are crospovidone, ...
Factive (Gemifloxacin Mesylate) - updated on RxList
Factive (Gemifloxacin Mesylate) drug description - FDA approved labeling for prescription drugs and medications at RxList.
Spectrophotometric method for the determination of Gemifloxacin ...
Spectrophotometric method for the determination of Gemifloxacin mesylate in bulk and Pharmaceutical formulations. murugesansugumaran's picture. Submitted by murugesansugumaran on Wed, 10/01/2008 - 06:33. ...
CDER New 11/3/2008
... Factive (gemifloxacin mesylate) Tablets, Oscient Pharmaceuticals Corp., Package Change; Monistat 3 Combination Pack (miconazole nitrate) Vaginal Cream, Johnson & Johnson Consumer & Personal Products Worldwide, Manufacturing Change ...
CDER New 10/8/2008
... Avelox In Sodium Chloride 0.8% In Plastic Container (moxifloxacin hydrochloride) IV Injection, Bayer Pharmaceuticals Corp., Labeling Revision; Factive (gemifloxacin mesylate) Tablets, Oscient Pharmaceuticals Corp., Labeling Revision ...
Avoiding Tendon Rupture and Tears
Factive (gemifloxacin mesylate). * Avelox (moxifloxacin HCL). * Cipro XR and Proquin XR (ciprofloxacin extended release). * Noroxin (norfloxacin). * Floxin (ofloxacin). * Cipro (ciprofloaxacin). The above antibiotics are used to treat ...
Oscient Pharmaceuticals Corporation Reports Third Quarter 2008 ...
... from $12.8 million in the third quarter of 2007. Revenues from the antibiotic FACTIVE® (gemifloxacin mesylate) tablets totaled $3.7 million in the third quarter of 2008, compared to $2.8 million in the third quarter of 2007. ...
LegalView Reveals Details of the FDA Mandated Black Box Warning ...
Factive, gemifloxacin mesylate, is an oral prescription drug that has also been linked to the tendon rupture as the most serious risk, although some other Factive side effects can be considered just as serious, including phototoxicity, ...
factive(gemifloxacin mesylate) tablet, film coated [oscient ...
updated date: feb 8, 2008 est.